HCID 53629212, compound → HCID 15952967, compound

HRID 1926853Notes

Reaction equation

HRID 1926853 reaction equation
COC1C=C(OC)C=CC=1C[NH:6][C:7]1[CH:8]=[CH:9][C:10]2[N:11]([C:13]([CH2:20][N:21]3[CH2:25][CH:24]([CH2:26][CH2:27][CH3:28])[CH2:23][C:22]3=[O:29])=[C:14]([C:16]([F:19])([F:18])[F:17])[N:15]=2)[N:12]=1>FC(F)(F)C(O)=O>[NH2:6][C:7]1[CH:8]=[CH:9][C:10]2[N:11]([C:13]([CH2:20][N:21]3[CH2:25][CH:24]([CH2:26][CH2:27][CH3:28])[CH2:23][C:22]3=[O:29])=[C:14]([C:16]([F:18])([F:17])[F:19])[N:15]=2)[N:12]=1

Participants

3

Procedure

1-{[6-[(2,4-dimethoxybenzyl)amino]-2-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]methyl}-4-propylpyrrolidin-2-one x268 (396 mg, 0.83 mmol) is stirred at room temperature in trifluoroacetic acid until its complete consumption (17 hours). After TFA removal under reduced pressure, the residue is taken in saturated K2CO3 aqueous solution and extracted with ethyl acetate (3×15 ml). The cumulated organic layers are dried over MgSO4, filtered and condensed under reduced pressure to yield the crude material which is purified by reverse phase preparative chromatography (gradient acetonitrile/water/TFA) to afford 1-{[6-amino-2-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]methyl}-4-propylpyrrolidin-2-one 53.

Workup

  1. customAfter TFA removal under reduced pressure
  2. extractionextracted with ethyl acetate (3×15 ml)
  3. dry with materialThe cumulated organic layers are dried over MgSO4
  4. filtrationfiltered
  5. customcondensed under reduced pressure
  6. customto yield the crude material which
  7. customis purified by reverse phase preparative chromatography (gradient acetonitrile/water/TFA)

Sources & evidence

ORD record
ord-c1c3ad5522ac4d9d80f5d3b9056513b3
Source dataset
uspto-grants-2012_05
Patent number
US08183241B2

Reaction notes

Loading…